Anthropic Launches Claude for Healthcare at JPM26, Targeting Enterprise AI Use Across Providers and Payers

Claude for Healthcare is designed to support enterprise healthcare workflows involving protected health information, offering HIPAA-ready infrastructure, healthcare-trained models, and native connections to widely used medical and scientific databases.

Anthropic has launched Claude for Healthcare, a new set of artificial intelligence tools built for health systems, payers, and life sciences organizations, as the company deepens its push into regulated clinical environments.

The announcement, made alongside the opening of the J.P. Morgan Healthcare Conference (JPM26), follows the company’s October launch of Claude for Life Sciences. 

Claude for Healthcare is designed to support enterprise healthcare workflows involving protected health information, offering HIPAA-ready infrastructure, healthcare-trained models, and native connections to widely used medical and scientific databases.

According to Anthropic, the platform integrates directly with the Centers for Medicare & Medicaid Services (CMS) Coverage Database, ICD-10 coding systems, the National Provider Identifier Registry, and PubMed. These integrations are intended to help organizations automate and streamline tasks such as prior authorization, medical coding, claims management, and clinical documentation.

Eric Kauderer-Abrams, head of biology and life sciences at Anthropic, said healthcare and life sciences represent one of the company’s largest strategic focus areas. He noted that the launch centers on connecting existing Claude models to the tools and data sources healthcare professionals already use, enabling AI-assisted workflows across clinical, administrative, and regulatory functions.

The move comes shortly after OpenAI introduced ChatGPT Health and OpenAI for Healthcare, underscoring growing competition among foundation model developers targeting enterprise healthcare use cases.

Anthropic said Claude for Healthcare can now be deployed in workflows that involve sensitive patient data, including prior authorization and coverage verification. Through CMS database access, the system can surface national and local coverage determinations, support claims accuracy, and highlight regional reimbursement differences. ICD-10 integrations support diagnosis and procedure lookups, while PubMed access allows retrieval of peer-reviewed biomedical literature.

The company also introduced new Agent Skills for FHIR development, aimed at helping developers connect healthcare systems more quickly and reduce interoperability errors.

Several healthcare organizations and life sciences companies—including Banner Health, Stanford Healthcare, Novo Nordisk, Sanofi, AbbVie, and Genmab—are already using Claude’s large language models for administrative automation, regulatory documentation, and clinical trial analysis.

Anthropic said it uses specific training and validation techniques to reduce hallucinations and improve the accuracy, citation, and reproducibility of outputs generated from medical databases. The company emphasized that its healthcare strategy is focused on enterprise customers rather than consumer-facing health applications.

On the life sciences side, Anthropic is expanding connectors to platforms such as Medidata, ClinicalTrials.gov, bioRxiv, medRxiv, Open Targets, ChEMBL, and Owkin, extending Claude’s use from preclinical research into clinical operations and regulatory affairs.

Stay tuned for more such updates on Digital Health News